Literature DB >> 17228077

The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X.

Stuart J Russell, Eugenie M Di Stefano, Mahmud T Naffati, Oliver Brown, Stephen Saltissi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17228077      PMCID： PMC1861378          DOI： 10.1136/hrt.2006.089904

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

Review 1.  Angina pectoris and normal coronary arteries: cardiac syndrome X.

Authors:  Filippo Crea; Gaetano A Lanza
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

2.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study.

Authors:  H G Kemp; R A Kronmal; R E Vlietstra; R L Frye
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

3.  Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome X) using a specific questionnaire.

Authors:  F Atienza; J A Velasco; S Brown; F Ridocci; J C Kaski
Journal:  Clin Cardiol       Date:  1999-04       Impact factor: 2.882

4.  Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.

Authors:  J C Kaski; G Rosano; S Gavrielides; L Chen
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

5.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.

Authors:  J C Kaski; G M Rosano; P Collins; P Nihoyannopoulos; A Maseri; P A Poole-Wilson
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094
  5 in total
  3 in total

1.  Angina in Women without Obstructive Coronary Artery Disease.

Authors:  Kamakki Banks; Monica Lo; Amit Khera
Journal:  Curr Cardiol Rev       Date:  2010-02

2.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

Review 3.  Definitions and incidence of cardiac syndrome X: review and analysis of clinical data.

Authors:  I A C Vermeltfoort; P G H M Raijmakers; I I Riphagen; D A M Odekerken; A F M Kuijper; A Zwijnenburg; G J J Teule
Journal:  Clin Res Cardiol       Date:  2010-04-21       Impact factor: 5.460
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.